3218 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Universal Vision Biotechnology Co., Ltd. engages in the sale of optical instruments, glasses, contact lenses, and glass ornament. It operates through the following business segments: Optometry, Ophthalmology, and Other. The Ophthalmology Business segment is responsible for providing ophthalmic clinics and hospital technical services and consultancy services and leasing services. The Optometry Business segment consists of the sales of glasses and peripheral equipment. The company was founded on August 3, 1994 and is headquartered in Taipei, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
3218 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company